Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study

Ameer Kakaje1, Mohammad Marwan Alhalabi2, Ayham Ghareeb2

  • 1Faculty of medicine, Damascus University, Damascus, Syria. ameer.kakaje@hotmail.com.

Scientific Reports
|April 23, 2020
PubMed

Insights

This study on childhood acute lymphoblastic leukemia (ALL) in Syria found distinct clinical and laboratory features, highlighting the need for localized treatment protocols. Findings suggest potential for rapid screening using hemoglobin and platelet counts during health crises.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Epidemiology

Background:

  • Childhood acute lymphoblastic leukemia (ALL) is a significant global health concern, particularly in developing nations.
  • Prognosis in childhood ALL is influenced by numerous clinical and laboratory factors, necessitating tailored treatment strategies.
  • Understanding local epidemiological data is crucial for optimizing management protocols in resource-limited settings.

Purpose of the Study:

  • To delineate the clinical and laboratory characteristics of childhood ALL in Syria.
  • To identify key prognostic factors and potential disparities compared to international literature.
  • To explore the feasibility of using basic hematological parameters for rapid patient prioritization in crisis situations.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 203 pediatric ALL patients (0-14 years).
  • Data collected from the Children's University Hospital, Syria's sole major pediatric cancer center during the study period.
  • Evaluation of patient demographics, presenting symptoms, ALL subclass, FAB classification, risk stratification, and hematological parameters.

Main Results:

  • A male predominance (60.9%) and peak incidence in the 5-9 year age group (48.8%) were observed.
  • Common presenting features included lymphadenopathy (82.9%), systemic symptoms (74.9%), T-ALL (20.2%), and L2 FAB classification (36.1%).
  • A high proportion of patients presented with abnormal platelet counts (89.3%) or low hemoglobin levels (88.8%); only 2.0% had normal levels for both.

Conclusions:

  • Syrian pediatric ALL cases exhibit unique features, including a high prevalence of T-ALL and L2 FAB classification, differing from global trends.
  • Normal hemoglobin and platelet counts at presentation were rare, suggesting their utility for rapid screening and prioritization in resource-limited settings.
  • Significant deviations in prognostic factors underscore the critical need for locally adapted treatment protocols to improve outcomes in developing countries.